Replies to post #63009 on NanoViricides Inc. (NNVC)

[daBoze]

That $20 will get us to Hawaii. Cox says Flucide has a market potential of $25 billion. If you assume a large pharmaceutical company licenses the product and agrees to a 15% licensing fee, that is $3.75 billion to NNVC. Also assume 200,000,000 shares outstanding at signature. That'a $18.75 per share. At a modest multiple of 25 times earnings the stock would be worth nearly $500 per share. Diwan and Seymour will vault into the ranks of the nations wealthiest individuals, and we peons won't do too badly either. And that says nothing about HIVCide or the other blockbuster drugs to come.